• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[采用血浆置换术纠正肺结核患者的支气管阻塞综合征及抗结核药物所致嗜酸性粒细胞增多症]

[Correction of bronchial obstructive syndrome and antituberculous drugs-induced eosinophilia in patients with pulmonary tuberculosis by using plasmapheresis].

作者信息

Shmelev E I, Stepanian I E

机构信息

Central NII of Tuberculosis RAMN, Moscow.

出版信息

Probl Tuberk. 1996(6):57-60.

PMID:9019774
Abstract

The paper provides the results of a follow-up of 70 patients with active pulmonary tuberculosis in whom the administration of antituberculous drugs induced eosinophilia and bronchial obstructive syndrome. To eliminate the side effects of antituberculous therapy, a plasmapheresis regimen was performed in 44 patients, the remaining patients were given only bronchodilators and antihistamine drugs. Plasmapheresis as a means for correcting drug-induced eosinophilia and bronchial obstructive syndrome was found to be more effective than drug therapy and, in some cases, enabled antituberculous therapy to be continued, without changing a combination of drugs. It is recommended that plasmapheresis should be used in cases of inadequate efficiency of conventional methods for correcting drug intolerance.

摘要

该论文提供了对70例活动性肺结核患者的随访结果,这些患者在接受抗结核药物治疗时出现了嗜酸性粒细胞增多和支气管阻塞综合征。为消除抗结核治疗的副作用,对44例患者实施了血浆置换方案,其余患者仅给予支气管扩张剂和抗组胺药物。结果发现,血浆置换作为纠正药物性嗜酸性粒细胞增多和支气管阻塞综合征的一种手段,比药物治疗更有效,在某些情况下,无需改变药物组合就能继续进行抗结核治疗。建议在传统方法纠正药物不耐受效果不佳的情况下使用血浆置换。

相似文献

1
[Correction of bronchial obstructive syndrome and antituberculous drugs-induced eosinophilia in patients with pulmonary tuberculosis by using plasmapheresis].[采用血浆置换术纠正肺结核患者的支气管阻塞综合征及抗结核药物所致嗜酸性粒细胞增多症]
Probl Tuberk. 1996(6):57-60.
2
[Therapeutic plasmapheresis in patients with destructive pulmonary tuberculosis].[治疗性血浆置换在破坏性肺结核患者中的应用]
Probl Tuberk Bolezn Legk. 2006(6):14-7.
3
[Clinical manifestations and specific features of the course of adenogenic tuberculosis in adults].[成人腺源性结核病的临床表现及病程特点]
Probl Tuberk. 2003(3):42-5.
4
[Follow-up of antitubercular treatment].[抗结核治疗的随访]
Rev Clin Esp. 1994 Sep;194(9):677-81.
5
[Two cases of multi-drug-resistant pulmonary tuberculosis with para-aminosalicylic acid (PAS)-induced hypothyroidism].两例对氨基水杨酸(PAS)诱发甲状腺功能减退的耐多药肺结核病例
Kekkaku. 2001 Oct;76(10):667-72.
6
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].[耐异烟肼或耐利福平结核病的特征及治疗结果]
Kekkaku. 2003 Oct;78(10):611-7.
7
[Administration of antituberculous drugs to subjects with basic diseases. 3. Clinical studies on the side effects of antituberculous drugs in patients with or without basic diseases, especially drug allergy].
Kekkaku. 1987 Dec;62(12):672-5.
8
[Individual approaches to complex treatment of disseminated tuberculous processes in adolescents].[青少年播散性结核病变复杂治疗的个体化方法]
Probl Tuberk Bolezn Legk. 2006(8):33-7.
9
[Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].[抗结核药物过敏反应的脱敏治疗——根据日本结核病学会指南对脱敏治疗的评估]
Kekkaku. 2000 Dec;75(12):699-704.
10
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.